

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.71646478 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.31813145 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.31813145 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.30539722 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.26427463 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.26427463 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.26427463 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.26427463 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.26427463 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 5.26427463 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.80205259 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.75669275 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.75038790 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 4.49395189 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.40925647 |
| 16 | response to peptidoglycan (GO:0032494) | 4.38036529 |
| 17 | positive thymic T cell selection (GO:0045059) | 4.19402067 |
| 18 | leukocyte aggregation (GO:0070486) | 4.08712629 |
| 19 | respiratory burst (GO:0045730) | 4.03064765 |
| 20 | regulation of mast cell degranulation (GO:0043304) | 4.02847750 |
| 21 | neutrophil activation (GO:0042119) | 3.97806219 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 3.90211862 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.84381208 |
| 24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.83311575 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.82506048 |
| 26 | granulocyte activation (GO:0036230) | 3.76429767 |
| 27 | response to host immune response (GO:0052572) | 3.74213048 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.74213048 |
| 29 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.71417364 |
| 30 | response to interleukin-15 (GO:0070672) | 3.69624086 |
| 31 | detection of bacterium (GO:0016045) | 3.64123067 |
| 32 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.60553284 |
| 33 | positive T cell selection (GO:0043368) | 3.55956940 |
| 34 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.53271957 |
| 35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.53131646 |
| 36 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.51909060 |
| 37 | myeloid cell activation involved in immune response (GO:0002275) | 3.51070470 |
| 38 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.49832839 |
| 39 | thymic T cell selection (GO:0045061) | 3.49059670 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.45468470 |
| 41 | negative regulation of cell killing (GO:0031342) | 3.45468470 |
| 42 | interferon-gamma production (GO:0032609) | 3.43936828 |
| 43 | positive regulation of mast cell activation (GO:0033005) | 3.43726650 |
| 44 | regulation of leukocyte degranulation (GO:0043300) | 3.43093982 |
| 45 | detection of biotic stimulus (GO:0009595) | 3.42192351 |
| 46 | cellular response to interleukin-15 (GO:0071350) | 3.41199646 |
| 47 | response to host (GO:0075136) | 3.40938053 |
| 48 | response to host defenses (GO:0052200) | 3.40938053 |
| 49 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.40938053 |
| 50 | defense response to fungus (GO:0050832) | 3.34873956 |
| 51 | detection of molecule of bacterial origin (GO:0032490) | 3.34632031 |
| 52 | response to muramyl dipeptide (GO:0032495) | 3.30516365 |
| 53 | regulation of mast cell activation (GO:0033003) | 3.30386900 |
| 54 | neutrophil mediated immunity (GO:0002446) | 3.29786592 |
| 55 | T cell selection (GO:0045058) | 3.27800648 |
| 56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.26563632 |
| 57 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.25988567 |
| 58 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.25877691 |
| 59 | negative T cell selection (GO:0043383) | 3.24315502 |
| 60 | microglial cell activation (GO:0001774) | 3.23679329 |
| 61 | leukocyte degranulation (GO:0043299) | 3.19809615 |
| 62 | macrophage activation (GO:0042116) | 3.14661968 |
| 63 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13822205 |
| 64 | negative thymic T cell selection (GO:0045060) | 3.13454566 |
| 65 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.13339376 |
| 66 | detection of other organism (GO:0098543) | 3.08890728 |
| 67 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.05697483 |
| 68 | negative regulation of interleukin-6 production (GO:0032715) | 3.04340908 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 3.04151832 |
| 70 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.04099012 |
| 71 | positive regulation of mast cell degranulation (GO:0043306) | 3.04099012 |
| 72 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.03631460 |
| 73 | type I interferon signaling pathway (GO:0060337) | 3.02527670 |
| 74 | cellular response to type I interferon (GO:0071357) | 3.02527670 |
| 75 | regulation of tolerance induction (GO:0002643) | 3.01157144 |
| 76 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.00898047 |
| 77 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.00898047 |
| 78 | response to type I interferon (GO:0034340) | 2.98880309 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.98130390 |
| 80 | erythrocyte maturation (GO:0043249) | 2.98071357 |
| 81 | NIK/NF-kappaB signaling (GO:0038061) | 2.95107224 |
| 82 | regulation of regulated secretory pathway (GO:1903305) | 2.94621290 |
| 83 | B cell mediated immunity (GO:0019724) | 2.94587262 |
| 84 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.92648450 |
| 85 | ribosomal small subunit assembly (GO:0000028) | 2.92416412 |
| 86 | defense response to protozoan (GO:0042832) | 2.90264722 |
| 87 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.89292280 |
| 88 | germinal center formation (GO:0002467) | 2.88375530 |
| 89 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.86290664 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84900679 |
| 91 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.83338911 |
| 92 | heme biosynthetic process (GO:0006783) | 2.82908020 |
| 93 | regulation of B cell differentiation (GO:0045577) | 2.82541210 |
| 94 | tolerance induction (GO:0002507) | 2.80666433 |
| 95 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.80347647 |
| 96 | regulation of cholesterol homeostasis (GO:2000188) | 2.80219993 |
| 97 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.79383502 |
| 98 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.79383502 |
| 99 | positive regulation of B cell differentiation (GO:0045579) | 2.79344931 |
| 100 | megakaryocyte development (GO:0035855) | 2.77893844 |
| 101 | regulation of RIG-I signaling pathway (GO:0039535) | 2.76839789 |
| 102 | myeloid leukocyte mediated immunity (GO:0002444) | 2.75471271 |
| 103 | regulation of superoxide anion generation (GO:0032928) | 2.75396404 |
| 104 | cellular extravasation (GO:0045123) | 2.75005929 |
| 105 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.73956765 |
| 106 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.73899789 |
| 107 | DNA deamination (GO:0045006) | 2.72690697 |
| 108 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.71459722 |
| 109 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.70749560 |
| 110 | valine metabolic process (GO:0006573) | 2.70700216 |
| 111 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.70259481 |
| 112 | regulation of response to interferon-gamma (GO:0060330) | 2.69247398 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.68132459 |
| 114 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.68132459 |
| 115 | glycine metabolic process (GO:0006544) | 2.67763768 |
| 116 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.67289108 |
| 117 | regulation of antigen processing and presentation (GO:0002577) | 2.65691664 |
| 118 | disruption of cells of other organism (GO:0044364) | 2.64312275 |
| 119 | killing of cells of other organism (GO:0031640) | 2.64312275 |
| 120 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.62657288 |
| 121 | Peyers patch development (GO:0048541) | 2.62657288 |
| 122 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.60714663 |
| 123 | negative regulation of innate immune response (GO:0045824) | 2.59707088 |
| 124 | plasma lipoprotein particle assembly (GO:0034377) | 2.59420921 |
| 125 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.59381397 |
| 126 | viral transcription (GO:0019083) | 2.58693060 |
| 127 | serine family amino acid catabolic process (GO:0009071) | 2.53481295 |
| 128 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.51853307 |
| 129 | mature B cell differentiation (GO:0002335) | 2.50784238 |
| 130 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.48702215 |
| 131 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.48362548 |
| 132 | T cell migration (GO:0072678) | 2.48174852 |
| 133 | phospholipid efflux (GO:0033700) | 2.47136339 |
| 134 | negative regulation of interleukin-12 production (GO:0032695) | 2.46667283 |
| 135 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.45535410 |
| 136 | T cell homeostasis (GO:0043029) | 2.44851115 |
| 137 | cysteine metabolic process (GO:0006534) | 2.44780743 |
| 138 | intestinal cholesterol absorption (GO:0030299) | 2.44604134 |
| 139 | translational termination (GO:0006415) | 2.44241885 |
| 140 | heme metabolic process (GO:0042168) | 2.42953553 |
| 141 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.42670811 |
| 142 | B cell receptor signaling pathway (GO:0050853) | 2.42436123 |
| 143 | positive regulation of humoral immune response (GO:0002922) | 2.42260703 |
| 144 | T cell receptor signaling pathway (GO:0050852) | 2.41749994 |
| 145 | mature B cell differentiation involved in immune response (GO:0002313) | 2.41456810 |
| 146 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.40647005 |
| 147 | tetrapyrrole biosynthetic process (GO:0033014) | 2.40009194 |
| 148 | pantothenate metabolic process (GO:0015939) | 2.39987687 |
| 149 | positive regulation of histone deacetylation (GO:0031065) | 2.37668143 |
| 150 | porphyrin-containing compound metabolic process (GO:0006778) | 2.36863427 |
| 151 | indole-containing compound catabolic process (GO:0042436) | 2.36674515 |
| 152 | indolalkylamine catabolic process (GO:0046218) | 2.36674515 |
| 153 | tryptophan catabolic process (GO:0006569) | 2.36674515 |
| 154 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.35055489 |
| 155 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.34908740 |
| 156 | folic acid metabolic process (GO:0046655) | 2.33180664 |
| 157 | positive regulation of isotype switching (GO:0045830) | 2.32740319 |
| 158 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.32307976 |
| 159 | regulation of natural killer cell differentiation (GO:0032823) | 2.29987809 |
| 160 | regulation of erythrocyte differentiation (GO:0045646) | 2.28534313 |
| 161 | negative regulation of phagocytosis (GO:0050765) | 2.26716700 |
| 162 | response to fungus (GO:0009620) | 2.26375662 |
| 163 | hepatocyte apoptotic process (GO:0097284) | 2.25786386 |
| 164 | amino-acid betaine metabolic process (GO:0006577) | 2.24643658 |
| 165 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.24425303 |
| 166 | regulation of triglyceride catabolic process (GO:0010896) | 2.24340834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.90144639 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.50711844 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.03063242 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.85059804 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80372217 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.67035719 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.65056851 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.56043213 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43951933 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.34069547 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27388711 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.25430681 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.17196133 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.13768760 |
| 15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.09043342 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.08935450 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01859608 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.99674381 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98594621 |
| 20 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97404536 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.94283742 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 1.93199793 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88323222 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.87848164 |
| 25 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87646742 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.84796973 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84399432 |
| 28 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.82588739 |
| 29 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82183661 |
| 30 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.81915859 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79912798 |
| 32 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.78436471 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.78345952 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.77223667 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.75225034 |
| 36 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.69535835 |
| 37 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.68743869 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.66971634 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.62064991 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61676984 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61466469 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.61287743 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61066888 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60044826 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.58904578 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56011103 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.55546198 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.54748624 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54532928 |
| 50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53805271 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53657395 |
| 52 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51059052 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50909471 |
| 54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.50559404 |
| 55 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.49979847 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45935536 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44601578 |
| 58 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43575103 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40972955 |
| 60 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.40250085 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.40121833 |
| 62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.39935595 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39172725 |
| 64 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.38313888 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35910393 |
| 66 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34399450 |
| 67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.33186871 |
| 68 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33072894 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32184418 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30517233 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30343854 |
| 72 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.28817159 |
| 73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.28420848 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26699891 |
| 75 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26157593 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25707403 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25176216 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.24668208 |
| 79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24488865 |
| 80 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23532889 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23510091 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22894118 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20484911 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20006983 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17878769 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17770511 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.15930834 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15894884 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14611308 |
| 90 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14328926 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14090672 |
| 92 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.13178959 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11960463 |
| 94 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11567640 |
| 95 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.10597631 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10299218 |
| 97 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09659994 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09603905 |
| 99 | P68_20966046_ChIP-Seq_HELA_Human | 1.08698551 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08191053 |
| 101 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.07675458 |
| 102 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.07527368 |
| 103 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.06029935 |
| 104 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04892051 |
| 105 | P300_27268052_Chip-Seq_Bcells_Human | 1.04748860 |
| 106 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.03634216 |
| 107 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03032583 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02662956 |
| 109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02228569 |
| 110 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.02044251 |
| 111 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01588785 |
| 112 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01028478 |
| 113 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00826709 |
| 114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00638153 |
| 115 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00409387 |
| 116 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00025989 |
| 117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00015122 |
| 118 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99889897 |
| 119 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99594291 |
| 120 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.99360201 |
| 121 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99004464 |
| 122 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97828777 |
| 123 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97518299 |
| 124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94289789 |
| 125 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.93885412 |
| 126 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91312278 |
| 127 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91189960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 2.87241349 |
| 2 | MP0003763_abnormal_thymus_physiology | 2.79022457 |
| 3 | MP0009840_abnormal_foam_cell | 2.72217493 |
| 4 | MP0000685_abnormal_immune_system | 2.66694475 |
| 5 | MP0005360_urolithiasis | 2.53945008 |
| 6 | MP0001800_abnormal_humoral_immune | 2.36089645 |
| 7 | MP0005671_abnormal_response_to | 2.34746988 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.24885552 |
| 9 | MP0008260_abnormal_autophagy | 2.24568173 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.23314339 |
| 11 | MP0003436_decreased_susceptibility_to | 2.21668061 |
| 12 | MP0001790_abnormal_immune_system | 2.20759826 |
| 13 | MP0005387_immune_system_phenotype | 2.20759826 |
| 14 | MP0009785_altered_susceptibility_to | 2.18614868 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.17998502 |
| 16 | MP0005365_abnormal_bile_salt | 2.07052842 |
| 17 | MP0004947_skin_inflammation | 2.05378063 |
| 18 | MP0002398_abnormal_bone_marrow | 2.01604925 |
| 19 | MP0001873_stomach_inflammation | 1.98406648 |
| 20 | MP0005025_abnormal_response_to | 1.97753229 |
| 21 | MP0010155_abnormal_intestine_physiology | 1.97708487 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 1.97602768 |
| 23 | MP0002723_abnormal_immune_serum | 1.96758325 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.93451746 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.93415154 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.92367808 |
| 27 | MP0001819_abnormal_immune_cell | 1.91169380 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.89403671 |
| 29 | MP0005085_abnormal_gallbladder_physiolo | 1.89098056 |
| 30 | MP0003866_abnormal_defecation | 1.89043830 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.88622410 |
| 32 | MP0004381_abnormal_hair_follicle | 1.85393403 |
| 33 | MP0003693_abnormal_embryo_hatching | 1.84052043 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.82401163 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.82401163 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.79068469 |
| 37 | MP0003303_peritoneal_inflammation | 1.78460161 |
| 38 | MP0000490_abnormal_crypts_of | 1.77944602 |
| 39 | MP0002722_abnormal_immune_system | 1.73310333 |
| 40 | MP0000716_abnormal_immune_system | 1.73282814 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.72544555 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.72503099 |
| 43 | MP0009278_abnormal_bone_marrow | 1.71587892 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.70407850 |
| 45 | MP0005451_abnormal_body_composition | 1.68158408 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.67179112 |
| 47 | MP0002405_respiratory_system_inflammati | 1.62708168 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.61653009 |
| 49 | MP0002419_abnormal_innate_immunity | 1.60170896 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.60159360 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.59676493 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.59361508 |
| 53 | MP0002429_abnormal_blood_cell | 1.56561927 |
| 54 | MP0001666_abnormal_nutrient_absorption | 1.53934965 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.53615015 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.50641510 |
| 57 | MP0002796_impaired_skin_barrier | 1.50070870 |
| 58 | MP0001853_heart_inflammation | 1.48549352 |
| 59 | MP0000609_abnormal_liver_physiology | 1.40611786 |
| 60 | MP0003828_pulmonary_edema | 1.40553537 |
| 61 | MP0003724_increased_susceptibility_to | 1.40129800 |
| 62 | MP0002132_abnormal_respiratory_system | 1.38108527 |
| 63 | MP0005310_abnormal_salivary_gland | 1.36913406 |
| 64 | MP0004147_increased_porphyrin_level | 1.35439299 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.32266595 |
| 66 | MP0002653_abnormal_ependyma_morphology | 1.32261395 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.31648660 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 1.30305782 |
| 69 | MP0003111_abnormal_nucleus_morphology | 1.29502389 |
| 70 | MP0002148_abnormal_hypersensitivity_rea | 1.27123863 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.24150962 |
| 72 | MP0002006_tumorigenesis | 1.23619798 |
| 73 | MP0008469_abnormal_protein_level | 1.22745102 |
| 74 | MP0003075_altered_response_to | 1.21638609 |
| 75 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19216965 |
| 76 | MP0001216_abnormal_epidermal_layer | 1.17733605 |
| 77 | MP0005501_abnormal_skin_physiology | 1.17521435 |
| 78 | MP0010329_abnormal_lipoprotein_level | 1.16845267 |
| 79 | MP0009764_decreased_sensitivity_to | 1.13753920 |
| 80 | MP0001851_eye_inflammation | 1.12661771 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 1.12642966 |
| 82 | MP0000343_altered_response_to | 1.11582510 |
| 83 | MP0005377_hearing/vestibular/ear_phenot | 1.10824530 |
| 84 | MP0003878_abnormal_ear_physiology | 1.10824530 |
| 85 | MP0002998_abnormal_bone_remodeling | 1.10763697 |
| 86 | MP0003183_abnormal_peptide_metabolism | 1.10318211 |
| 87 | MP0001764_abnormal_homeostasis | 1.07301897 |
| 88 | MP0006082_CNS_inflammation | 1.05518612 |
| 89 | MP0005083_abnormal_biliary_tract | 1.05498688 |
| 90 | MP0002019_abnormal_tumor_incidence | 1.03447936 |
| 91 | MP0000858_altered_metastatic_potential | 1.02912197 |
| 92 | MP0008004_abnormal_stomach_pH | 0.99772404 |
| 93 | MP0005166_decreased_susceptibility_to | 0.99271681 |
| 94 | MP0004510_myositis | 0.98509738 |
| 95 | MP0000604_amyloidosis | 0.97535932 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.96171705 |
| 97 | MP0009931_abnormal_skin_appearance | 0.93431772 |
| 98 | MP0003252_abnormal_bile_duct | 0.92944049 |
| 99 | MP0001663_abnormal_digestive_system | 0.92481778 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.91614743 |
| 101 | MP0008057_abnormal_DNA_replication | 0.89467556 |
| 102 | MP0004883_abnormal_blood_vessel | 0.88713880 |
| 103 | MP0005636_abnormal_mineral_homeostasis | 0.88278255 |
| 104 | MP0003077_abnormal_cell_cycle | 0.87150336 |
| 105 | MP0004019_abnormal_vitamin_homeostasis | 0.86457900 |
| 106 | MP0010352_gastrointestinal_tract_polyps | 0.83772056 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.83752398 |
| 108 | MP0009763_increased_sensitivity_to | 0.82118071 |
| 109 | MP0000383_abnormal_hair_follicle | 0.81811537 |
| 110 | MP0002254_reproductive_system_inflammat | 0.81515796 |
| 111 | MP0003868_abnormal_feces_composition | 0.81504915 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.80891991 |
| 113 | MP0000477_abnormal_intestine_morphology | 0.80569101 |
| 114 | MP0005332_abnormal_amino_acid | 0.80200838 |
| 115 | MP0005164_abnormal_response_to | 0.79198304 |
| 116 | MP0005390_skeleton_phenotype | 0.79155115 |
| 117 | MP0005174_abnormal_tail_pigmentation | 0.77936077 |
| 118 | MP0008058_abnormal_DNA_repair | 0.77132407 |
| 119 | MP0000598_abnormal_liver_morphology | 0.75730358 |
| 120 | MP0002118_abnormal_lipid_homeostasis | 0.75030934 |
| 121 | MP0000377_abnormal_hair_follicle | 0.74973176 |
| 122 | MP0002098_abnormal_vibrissa_morphology | 0.74357275 |
| 123 | MP0003329_amyloid_beta_deposits | 0.70373822 |
| 124 | MP0003448_altered_tumor_morphology | 0.69289524 |
| 125 | MP0002933_joint_inflammation | 0.67309286 |
| 126 | MP0003690_abnormal_glial_cell | 0.66874961 |
| 127 | MP0008874_decreased_physiological_sensi | 0.65888190 |
| 128 | MP0003221_abnormal_cardiomyocyte_apopto | 0.64274831 |
| 129 | MP0003795_abnormal_bone_structure | 0.59731543 |
| 130 | MP0001986_abnormal_taste_sensitivity | 0.57948312 |
| 131 | MP0002332_abnormal_exercise_endurance | 0.55452289 |
| 132 | MP0002693_abnormal_pancreas_physiology | 0.54364231 |
| 133 | MP0000249_abnormal_blood_vessel | 0.53399648 |
| 134 | MP0008873_increased_physiological_sensi | 0.52762444 |
| 135 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52664565 |
| 136 | MP0003011_delayed_dark_adaptation | 0.50383119 |
| 137 | MP0000015_abnormal_ear_pigmentation | 0.49162690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pustule (HP:0200039) | 4.78203900 |
| 2 | Optic neuritis (HP:0100653) | 4.51227601 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.51227601 |
| 4 | Poikilocytosis (HP:0004447) | 3.99030518 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.87572199 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.77826936 |
| 7 | Increased IgE level (HP:0003212) | 3.74603797 |
| 8 | IgM deficiency (HP:0002850) | 3.63947976 |
| 9 | Chronic otitis media (HP:0000389) | 3.55387889 |
| 10 | T lymphocytopenia (HP:0005403) | 3.54854372 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.54533402 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 3.49807050 |
| 13 | Abnormality of T cell number (HP:0011839) | 3.41271280 |
| 14 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.39972476 |
| 15 | Nasal polyposis (HP:0100582) | 3.24633160 |
| 16 | Acanthocytosis (HP:0001927) | 3.16875302 |
| 17 | Abnormality of T cells (HP:0002843) | 3.16480593 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 3.15549437 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.11785493 |
| 20 | Abnormal number of erythroid precursors (HP:0012131) | 3.11735970 |
| 21 | Inflammation of the large intestine (HP:0002037) | 3.11125445 |
| 22 | Petechiae (HP:0000967) | 3.11063493 |
| 23 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.09677300 |
| 24 | Recurrent bronchitis (HP:0002837) | 3.09074283 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 3.07887856 |
| 26 | Recurrent viral infections (HP:0004429) | 3.06906210 |
| 27 | Keratoconjunctivitis (HP:0001096) | 3.05962371 |
| 28 | Hypochromic anemia (HP:0001931) | 3.01025036 |
| 29 | Gingivitis (HP:0000230) | 2.98928309 |
| 30 | Microcytic anemia (HP:0001935) | 2.97208620 |
| 31 | Abnormality of the nasal mucosa (HP:0000433) | 2.93862704 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 2.88199860 |
| 33 | Increased IgM level (HP:0003496) | 2.84955792 |
| 34 | Spontaneous hematomas (HP:0007420) | 2.83695008 |
| 35 | Episodic fever (HP:0001954) | 2.83062810 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 2.81198755 |
| 37 | Colitis (HP:0002583) | 2.78152765 |
| 38 | Meningitis (HP:0001287) | 2.77031712 |
| 39 | Recurrent sinusitis (HP:0011108) | 2.73288726 |
| 40 | Prolonged bleeding time (HP:0003010) | 2.72758464 |
| 41 | Combined immunodeficiency (HP:0005387) | 2.71823593 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 2.71033468 |
| 43 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.71033468 |
| 44 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.71033468 |
| 45 | Epistaxis (HP:0000421) | 2.68506250 |
| 46 | Recurrent abscess formation (HP:0002722) | 2.66182144 |
| 47 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.64301293 |
| 48 | Encephalitis (HP:0002383) | 2.63676684 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.62281837 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.62110864 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.62110864 |
| 52 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.58185198 |
| 53 | Anorexia (HP:0002039) | 2.57474234 |
| 54 | Abnormality of the fingertips (HP:0001211) | 2.57162811 |
| 55 | Loss of speech (HP:0002371) | 2.55361087 |
| 56 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55049792 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 2.54721771 |
| 58 | Myositis (HP:0100614) | 2.54353564 |
| 59 | Severe combined immunodeficiency (HP:0004430) | 2.53347349 |
| 60 | Chest pain (HP:0100749) | 2.53142223 |
| 61 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.52846479 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.48825675 |
| 63 | Impaired platelet aggregation (HP:0003540) | 2.48764832 |
| 64 | Abnormal platelet function (HP:0011869) | 2.48764832 |
| 65 | Thrombocytosis (HP:0001894) | 2.45349210 |
| 66 | Purpura (HP:0000979) | 2.44605291 |
| 67 | Poikiloderma (HP:0001029) | 2.43454732 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.43291574 |
| 69 | Gingival bleeding (HP:0000225) | 2.41456674 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.40429111 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.39164867 |
| 72 | Reticulocytosis (HP:0001923) | 2.38676370 |
| 73 | Cheilitis (HP:0100825) | 2.37953302 |
| 74 | Granulocytopenia (HP:0001913) | 2.37421150 |
| 75 | Osteomyelitis (HP:0002754) | 2.35861978 |
| 76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.35723531 |
| 77 | Eosinophilia (HP:0001880) | 2.35335462 |
| 78 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33247764 |
| 79 | Obstructive lung disease (HP:0006536) | 2.33247764 |
| 80 | Sepsis (HP:0100806) | 2.32243659 |
| 81 | Abnormality of reticulocytes (HP:0004312) | 2.31745569 |
| 82 | Urticaria (HP:0001025) | 2.31707823 |
| 83 | B lymphocytopenia (HP:0010976) | 2.29877227 |
| 84 | Abnormality of B cell number (HP:0010975) | 2.29877227 |
| 85 | Polycythemia (HP:0001901) | 2.27972111 |
| 86 | Recurrent skin infections (HP:0001581) | 2.26280609 |
| 87 | Verrucae (HP:0200043) | 2.25623807 |
| 88 | Papilloma (HP:0012740) | 2.25623807 |
| 89 | Entropion (HP:0000621) | 2.25565830 |
| 90 | Slow saccadic eye movements (HP:0000514) | 2.23807755 |
| 91 | Gangrene (HP:0100758) | 2.23681042 |
| 92 | Vasculitis (HP:0002633) | 2.23122224 |
| 93 | Amyloidosis (HP:0011034) | 2.22666751 |
| 94 | Joint hemorrhage (HP:0005261) | 2.21751886 |
| 95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.21386332 |
| 96 | Reticulocytopenia (HP:0001896) | 2.19424146 |
| 97 | Hyperbilirubinemia (HP:0002904) | 2.18840295 |
| 98 | Lymphopenia (HP:0001888) | 2.18196238 |
| 99 | Hepatosplenomegaly (HP:0001433) | 2.18072335 |
| 100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.17979704 |
| 101 | Leukocytosis (HP:0001974) | 2.15162457 |
| 102 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.14729623 |
| 103 | Cellulitis (HP:0100658) | 2.13783369 |
| 104 | Intrahepatic cholestasis (HP:0001406) | 2.13572530 |
| 105 | Xanthomatosis (HP:0000991) | 2.12754964 |
| 106 | Hypochromic microcytic anemia (HP:0004840) | 2.12428273 |
| 107 | Vacuolated lymphocytes (HP:0001922) | 2.11193192 |
| 108 | Hyperlipoproteinemia (HP:0010980) | 2.11117684 |
| 109 | Pulmonary embolism (HP:0002204) | 2.09951988 |
| 110 | Glomerulopathy (HP:0100820) | 2.09922687 |
| 111 | Stomatitis (HP:0010280) | 2.09013839 |
| 112 | Thyroiditis (HP:0100646) | 2.08770349 |
| 113 | Mediastinal lymphadenopathy (HP:0100721) | 2.07659917 |
| 114 | Arterial thrombosis (HP:0004420) | 2.07633345 |
| 115 | IgG deficiency (HP:0004315) | 2.05400111 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 2.04834357 |
| 117 | Hypertensive crisis (HP:0100735) | 2.02182627 |
| 118 | Prolonged partial thromboplastin time (HP:0003645) | 2.01404352 |
| 119 | Bronchitis (HP:0012387) | 2.01297209 |
| 120 | Skin rash (HP:0000988) | 1.99707464 |
| 121 | Abnormality of macrophages (HP:0004311) | 1.99585023 |
| 122 | Increased serum ferritin (HP:0003281) | 1.99460254 |
| 123 | Acne (HP:0001061) | 1.99069633 |
| 124 | Seborrheic dermatitis (HP:0001051) | 1.98833118 |
| 125 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.98431706 |
| 126 | Hyperglycinuria (HP:0003108) | 1.97849176 |
| 127 | Joint swelling (HP:0001386) | 1.97177910 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 1.95746142 |
| 129 | Abnormality of the pleura (HP:0002103) | 1.94971990 |
| 130 | Lymphoma (HP:0002665) | 1.94908362 |
| 131 | Keratitis (HP:0000491) | 1.94688683 |
| 132 | Chronic sinusitis (HP:0011109) | 1.94493970 |
| 133 | Skin ulcer (HP:0200042) | 1.93267799 |
| 134 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92721020 |
| 135 | Hemoptysis (HP:0002105) | 1.91898986 |
| 136 | Acute hepatic failure (HP:0006554) | 1.90841514 |
| 137 | Orchitis (HP:0100796) | 1.90774232 |
| 138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90541763 |
| 139 | Basal cell carcinoma (HP:0002671) | 1.90024752 |
| 140 | Premature loss of primary teeth (HP:0006323) | 1.85783038 |
| 141 | Recurrent pneumonia (HP:0006532) | 1.85208563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.91382719 |
| 2 | GRK6 | 3.11308275 |
| 3 | BLK | 2.80760748 |
| 4 | MAP3K10 | 2.67813151 |
| 5 | TXK | 2.44518386 |
| 6 | STK10 | 2.28687997 |
| 7 | IRAK3 | 2.24051208 |
| 8 | PRPF4B | 2.19503039 |
| 9 | TYK2 | 2.19481520 |
| 10 | ZAP70 | 2.11367113 |
| 11 | TAOK3 | 2.09707380 |
| 12 | FGFR4 | 2.09119207 |
| 13 | ERN1 | 2.06624659 |
| 14 | BTK | 1.81509205 |
| 15 | IKBKE | 1.74287670 |
| 16 | EEF2K | 1.71636483 |
| 17 | PIM1 | 1.66120812 |
| 18 | ITK | 1.65977542 |
| 19 | NLK | 1.64090884 |
| 20 | MAP2K3 | 1.59052218 |
| 21 | TBK1 | 1.54400227 |
| 22 | MAP3K14 | 1.52875104 |
| 23 | SIK3 | 1.50899725 |
| 24 | DYRK3 | 1.48310728 |
| 25 | IRAK4 | 1.44656060 |
| 26 | TAOK2 | 1.44146379 |
| 27 | NEK2 | 1.41578049 |
| 28 | TEC | 1.40524004 |
| 29 | CDK12 | 1.40328322 |
| 30 | SYK | 1.39669995 |
| 31 | IKBKB | 1.39295728 |
| 32 | JAK3 | 1.39257653 |
| 33 | EPHB1 | 1.37109366 |
| 34 | MARK3 | 1.33323766 |
| 35 | CSK | 1.31023721 |
| 36 | MST4 | 1.28739574 |
| 37 | JAK1 | 1.27066897 |
| 38 | RPS6KA4 | 1.25123845 |
| 39 | FGR | 1.21536585 |
| 40 | MAP3K3 | 1.19667220 |
| 41 | MATK | 1.15777776 |
| 42 | MAP2K2 | 1.14132914 |
| 43 | MAP3K11 | 1.12797628 |
| 44 | EIF2AK1 | 1.11213787 |
| 45 | NME2 | 1.08909190 |
| 46 | HCK | 1.05900976 |
| 47 | TAOK1 | 1.05843378 |
| 48 | CDK4 | 1.04471111 |
| 49 | STK4 | 1.00692880 |
| 50 | MAPK11 | 0.99197550 |
| 51 | BCKDK | 0.98784341 |
| 52 | TRIB3 | 0.98537404 |
| 53 | PTK6 | 0.97170923 |
| 54 | LCK | 0.95524228 |
| 55 | JAK2 | 0.93651709 |
| 56 | MARK2 | 0.93587837 |
| 57 | RPS6KB2 | 0.93371276 |
| 58 | KSR2 | 0.92331046 |
| 59 | LRRK2 | 0.91374413 |
| 60 | SMG1 | 0.91108864 |
| 61 | CDK19 | 0.87858295 |
| 62 | CHUK | 0.86631645 |
| 63 | GRK1 | 0.86529880 |
| 64 | KDR | 0.86189648 |
| 65 | TNK2 | 0.85830961 |
| 66 | BRSK2 | 0.85703668 |
| 67 | HIPK2 | 0.84901581 |
| 68 | PKN2 | 0.83230359 |
| 69 | STK24 | 0.83207247 |
| 70 | SIK1 | 0.82828995 |
| 71 | DYRK1B | 0.82684292 |
| 72 | LYN | 0.82654783 |
| 73 | PDK1 | 0.82640665 |
| 74 | TESK1 | 0.82384051 |
| 75 | FLT3 | 0.82325471 |
| 76 | IRAK2 | 0.81479062 |
| 77 | ARAF | 0.79380882 |
| 78 | TLK1 | 0.77087981 |
| 79 | MAP3K7 | 0.76796509 |
| 80 | KIT | 0.76260184 |
| 81 | MAP2K6 | 0.75329325 |
| 82 | MAP3K5 | 0.73203155 |
| 83 | EPHA3 | 0.72488923 |
| 84 | MAPKAPK3 | 0.72029174 |
| 85 | PDPK1 | 0.71387660 |
| 86 | GRK7 | 0.69985541 |
| 87 | CAMKK1 | 0.68668684 |
| 88 | FES | 0.68151584 |
| 89 | IRAK1 | 0.67959705 |
| 90 | RPS6KA5 | 0.67317721 |
| 91 | MAPK12 | 0.65211209 |
| 92 | MAP2K4 | 0.63790020 |
| 93 | MAP4K2 | 0.62728694 |
| 94 | MAP3K8 | 0.62531461 |
| 95 | ALK | 0.62093952 |
| 96 | RIPK1 | 0.60943501 |
| 97 | ACVR1B | 0.57948132 |
| 98 | MELK | 0.57660078 |
| 99 | FYN | 0.57475284 |
| 100 | RPS6KC1 | 0.57366678 |
| 101 | RPS6KL1 | 0.57366678 |
| 102 | CLK1 | 0.56412272 |
| 103 | MAP3K1 | 0.56375985 |
| 104 | MAPK4 | 0.56263570 |
| 105 | FGFR3 | 0.55936256 |
| 106 | WEE1 | 0.55919564 |
| 107 | CSF1R | 0.52264362 |
| 108 | MAP3K13 | 0.51994338 |
| 109 | TSSK6 | 0.51772727 |
| 110 | STK38 | 0.51660870 |
| 111 | TGFBR2 | 0.51660565 |
| 112 | RPS6KA6 | 0.51210063 |
| 113 | RAF1 | 0.50742734 |
| 114 | CDK3 | 0.50240317 |
| 115 | CAMKK2 | 0.49995476 |
| 116 | MAPK15 | 0.49646083 |
| 117 | PRKCQ | 0.48746199 |
| 118 | SIK2 | 0.48061780 |
| 119 | RIPK4 | 0.47866089 |
| 120 | MAP3K12 | 0.44801479 |
| 121 | STK16 | 0.44762716 |
| 122 | MAPKAPK2 | 0.44083981 |
| 123 | TESK2 | 0.43144542 |
| 124 | PIM2 | 0.41311198 |
| 125 | PRKD2 | 0.40646266 |
| 126 | BUB1 | 0.39852514 |
| 127 | EPHA2 | 0.39658454 |
| 128 | YES1 | 0.38998296 |
| 129 | EIF2AK3 | 0.37919004 |
| 130 | BMX | 0.37776108 |
| 131 | MAPK7 | 0.37514375 |
| 132 | PRKCI | 0.37301774 |
| 133 | CDC42BPA | 0.37139072 |
| 134 | RPS6KA1 | 0.36509344 |
| 135 | STK11 | 0.35089948 |
| 136 | BRAF | 0.34261881 |
| 137 | PTK2B | 0.32976047 |
| 138 | PRKCD | 0.31244502 |
| 139 | MAP3K6 | 0.30950687 |
| 140 | PRKCZ | 0.30708238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.48485683 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.28952397 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.28809921 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 2.13355648 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97019480 |
| 6 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.95740735 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90109634 |
| 8 | ABC transporters_Homo sapiens_hsa02010 | 1.89970104 |
| 9 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.88119767 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.87011270 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85694964 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82774592 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.77205948 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.77052889 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74221943 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.72089837 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.71278717 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69679373 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.69271277 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.69229245 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65558677 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63541885 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.59767347 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.57720259 |
| 25 | Ribosome_Homo sapiens_hsa03010 | 1.57033308 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.51079088 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.49628386 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48879034 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48872400 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.48762257 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48465357 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46748253 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46234881 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42795492 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42221667 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41621931 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38087538 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34222610 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.32523955 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.31801663 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.31080167 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30875834 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28866933 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.28459775 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.26639085 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25587638 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.22164308 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20600673 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.19091783 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18879560 |
| 51 | DNA replication_Homo sapiens_hsa03030 | 1.18378580 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17242656 |
| 53 | Asthma_Homo sapiens_hsa05310 | 1.16921053 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14294409 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04789831 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04783107 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03921272 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02498162 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 1.01941737 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 1.00934977 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 1.00301769 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99913987 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98257932 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.97562551 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.97183448 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.96489539 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93375934 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.91740816 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.91641679 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90734455 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89864084 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88970897 |
| 73 | Base excision repair_Homo sapiens_hsa03410 | 0.88946150 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.87957541 |
| 75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84093704 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83010180 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.82550910 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82156384 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.80073759 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79168900 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.78489380 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.78156109 |
| 83 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.77653633 |
| 84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77071073 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75710353 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73723009 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73229828 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72892946 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71234739 |
| 90 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71069266 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70621681 |
| 92 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68482753 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68277144 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.68177532 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68152237 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67884493 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67521156 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67361972 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66996072 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66537404 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65547057 |
| 102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65316793 |
| 103 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64828219 |
| 104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63897759 |
| 105 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63767413 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.62931631 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62654715 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60250271 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.59838696 |
| 110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59488858 |
| 111 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58477604 |
| 112 | Bile secretion_Homo sapiens_hsa04976 | 0.58199142 |
| 113 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53653817 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53506275 |
| 115 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53285966 |
| 116 | Mismatch repair_Homo sapiens_hsa03430 | 0.53155504 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52500761 |
| 118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52338886 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50979031 |
| 120 | Homologous recombination_Homo sapiens_hsa03440 | 0.49920056 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49900116 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49885313 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49818162 |
| 124 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48041824 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47993351 |
| 126 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47326525 |
| 127 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46828805 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46533105 |
| 129 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46482466 |
| 130 | Allograft rejection_Homo sapiens_hsa05330 | 0.46089519 |
| 131 | Spliceosome_Homo sapiens_hsa03040 | 0.45317036 |
| 132 | Tuberculosis_Homo sapiens_hsa05152 | 0.45036498 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43857673 |
| 134 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43399407 |
| 135 | Bladder cancer_Homo sapiens_hsa05219 | 0.43024214 |
| 136 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.41220651 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40017216 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.38463247 |
| 139 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37940654 |
| 140 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35180273 |
| 141 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34934882 |
| 142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34596768 |
| 143 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33097561 |
| 144 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.32504969 |
| 145 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31456600 |
| 146 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30925465 |
| 147 | Colorectal cancer_Homo sapiens_hsa05210 | 0.27090521 |
| 148 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26848541 |
| 149 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26086481 |
| 150 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.26078417 |
| 151 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25350966 |

